Formosa Pharmaceuticals Investors
Corporate Governance
Board of Directors
Major Policies
- Article of incorporation
- Corporate governance structure
- Management of assets
- Management of related party transactions
- Management of the prevention of insider trading
- Procedures and methods for acquiring or disposing of assets
- Ethical corporate management best practice principles acquiring or disposing of assets
- Code of ethics
- Procedures for election of directors
- Operational procedures for endorsements and guarantees
- Corporate governance best practice principles
- Corporate sustainable development best practice principles
- Operational procedures for loaning funds to others
- Rules of procedure for shareholders meetings
Major Resolutions
ethics mailbox
We uphold integrity in all our business activities and do not tolerate corruption or any form of fraud. If you discover any suspicious behavior by our employees or any person related to our company, or any violation of human rights, code of conduct, or code of integrity, please inform us via the following complaint email address, along with specific evidence: ethics@formosapharma.com
News Highlight
Formosa Pharmaceuticals Announces Licensing Agreement with Samil Pharmaceuticals, Co., Ltd, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery
2026-01-08
Formosa Pharmaceuticals Announces Licensing Agreement with Samil Pharmaceuticals, Co., Ltd, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery TAIPEI – January
